We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$820M
AUM Growth
+$14.5M
Cap. Flow
-$58.3M
Cap. Flow %
-7.11%
Top 10 Hldgs %
15.04%
Holding
537
New
56
Increased
73
Reduced
203
Closed
92

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$6.12M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$5.37M
3
ST icon
Sensata Technologies
ST
+$5.01M
4
DRIO icon
DarioHealth
DRIO
+$3.05M
5
TWTR
Twitter, Inc.
TWTR
+$3.05M

Sector Composition

Rank Sector Weight
1 Technology 24.55%
2 Healthcare 17.09%
3 Industrials 12.67%
4 Materials 10.49%
5 Consumer Discretionary 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
76
Regeneron Pharmaceuticals
REGN
$82.2B
$3.24M 0.39%
6,844
-432
-6% -$210K
USAK
77
DELISTED
USA Truck Inc
USAK
$3.23M 0.39%
169,000
+12,465
+8% +$165K
LAZ icon
78
Lazard
LAZ
$4.24B
$3.22M 0.39%
74,020
-2,401
-3% -$102K
NVCR icon
79
NovoCure
NVCR
$2.05B
$3.21M 0.39%
24,286
+2,987
+14% +$472K
HASI icon
80
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.37B
$3.17M 0.39%
56,455
-3,918
-6% -$236K
MLM icon
81
Martin Marietta Materials
MLM
$32.7B
$3.16M 0.39%
9,415
+1,048
+13% +$335K
CRM icon
82
Salesforce
CRM
$158B
$3.13M 0.38%
14,785
-902
-6% -$201K
NOVT icon
83
Novanta
NOVT
$6.32B
$3.13M 0.38%
23,706
-2,493
-10% -$328K
TBBK icon
84
The Bancorp
TBBK
$2.83B
$3.05M 0.37%
147,072
-15,543
-10% -$302K
VMC icon
85
Vulcan Materials
VMC
$36.3B
$3.05M 0.37%
18,055
+3,470
+24% +$563K
CIEN icon
86
Ciena
CIEN
$61.2B
$2.97M 0.36%
54,303
-1,346
-2% -$72.4K
BIDU icon
87
Baidu
BIDU
$35.6B
$2.96M 0.36%
13,588
-1,412
-9% -$369K
PI icon
88
Impinj
PI
$5.49B
$2.95M 0.36%
51,883
-5,485
-10% -$323K
PFE icon
89
Pfizer
PFE
$150B
$2.92M 0.36%
80,697
-5,408
-6% -$192K
TGT icon
90
Target
TGT
$69.9B
$2.92M 0.36%
14,739
-601
-4% -$112K
CYRX icon
91
CryoPort
CYRX
$750M
$2.91M 0.35%
55,908
-5,894
-10% -$358K
SYNH
92
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$2.9M 0.35%
38,301
+34,633
+944% +$2.61M
KOPN icon
93
Kopin
KOPN
$933M
$2.9M 0.35%
276,295
-244,546
-47% -$1.85M
AMRS
94
DELISTED
Amyris Inc.
AMRS
$2.86M 0.35%
149,825
-17,697
-11% -$257K
HCI icon
95
HCI Group
HCI
$2.28B
$2.71M 0.33%
35,327
-3,298
-9% -$208K
AX icon
96
Axos Financial
AX
$5.68B
$2.71M 0.33%
57,681
-715
-1% -$32.2K
GRWG icon
97
GrowGeneration
GRWG
$105M
$2.62M 0.32%
52,628
-15,840
-23% -$790K
LDL
98
DELISTED
Lydall, Inc.
LDL
$2.61M 0.32%
77,455
-8,217
-10% -$281K
DRIO icon
99
DarioHealth
DRIO
$72.9M
$2.61M 0.32%
+6,773
New +$3.05M
RMNI icon
100
Rimini Street
RMNI
$445M
$2.6M 0.32%
289,438
-30,651
-10% -$237K

Similar funds

Essex Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Essex Investment Management held 537 positions worth $820M, up 1.8% from $806M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Essex Investment Management withdrew a net $58.3M in Q1 2021, closing 92 positions and reducing 203 holdings. Its most notable exit was VeriSign, an estimated $5.32M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Essex Investment Management opened a new position in CRISPR Therapeutics worth $4.33M.

  • Essex Investment Management's largest Q1 2021 buy was CRISPR Therapeutics: 35,540 shares worth $4.33M.
  • Essex Investment Management added most to AT&T in Q1 2021, an estimated $6.12M increase.
  • Essex Investment Management's biggest Q1 2021 reduction was Teladoc Health, cutting an estimated $8.61M.
  • Essex Investment Management fully exited VeriSign in Q1 2021, selling an estimated $5.32M.
  • Essex Investment Management's ten largest holdings make up 15% of its $820M portfolio in Q1 2021.
  • Essex Investment Management opened 56 new positions and closed 92 in Q1 2021.
  • Essex Investment Management's portfolio value rose 1.8% quarter-over-quarter to $820M.

Based on Essex Investment Management's 13F filing for Q1 2021, filed 12 May 2021.